Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
DCM Shriram Fine Chemicals Ltd (DSFCL)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544703 NSE: DSFCL Chemicals | Small Cap | DCM Shriram FineChem Share Price
₹25.10 -0.50 (-1.95%)
As on 11-Sep'26 16:59
DCM Shriram Fine Chemicals Ltd (DSFCL)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544703 NSE: DSFCL Chemicals | Small Cap | DCM Shriram FineChem Share Price
₹25.10 -0.50 (-1.95%)
As on 11-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹218 Cr.
Current Price
₹25.1
52-Week Low / High
₹17 / 52
TTM EPS
₹-0.4
TTM Sales
₹386 Cr.
Book Value per Share
₹24.6
P/E Ratio
0.00
Industry PE
49.5
Price to Book (P/B)
1.02
Lower than its 5-year historical median
Price to Sales (P/S)
0.57
In line with its 5-year historical median
EV/EBITDA
27.79
Lower than its 5-year historical median
Dividend Yield
1.59%
Profitability Efficiency
Return on Equity (ROE)
-1.73%
Underperforms industry median
Return on Capital Employed (ROCE)
-0.76%
Underperforms industry median
Return on Assets (ROA)
-1.17%
Operating Profit Margin
1.8%
Net Profit Margin
-0.92%
Gross Profit Margin
1.4%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-10.21%
Operating Profit Growth (1 Year)
-
-88.93%
Net Profit Growth (1 Year)
-
-118.45%
Asset Quality
Promoter Holding
50.11%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹196 Cr.
Equity
₹17.4 Cr.
Face Value
₹2
All Time Low / High
₹17.30 / 52.49
Check Before You Invest
Quality
Not GoodValuation
UndervaluedCheck Valuation charts
Price Trend
Semi Strong
Is DCM Shriram Fine Chemicals Ltd a good quality company?
DCM Shriram Fine Chemicals Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does DCM Shriram Fine Chemicals Ltd performance compare with that of its Peers?
Revenue growth of DCM Shriram Fine Chemicals Ltd vs industry peers?
DCM Shriram Fine Chemicals Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 0.00%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of DCM Shriram Fine Chemicals Ltd?
Promoters hold 50.11% of the DCM Shriram Fine Chemicals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of DCM Shriram Fine Chemicals Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
DCM Shriram Fine Chemicals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'25 | Mar'26 | TTM | |
|---|---|---|---|
| ROCE % ⓘ | 12.5% | -1.3% | - |
| Value Creation Index ⓘ | -0.1 | -1.1 | - |
Growth Parameters ⓘ |
|||
| Sales ⓘ | 429 | 386 | 386 |
| Sales YoY Gr. | - | -10.2% | - |
| Adj EPS ⓘ | 0 | -0.2 | -0.5 |
| YoY Gr. | - | NA | - |
| BVPS (₹) ⓘ | 0 | 23 | 23.3 |
| Adj Net Profit ⓘ | 17.7 | -2.1 | -4 |
| Cash Flow from Ops. ⓘ | 14.7 | 16.3 | - |
| Debt/CF from Ops. ⓘ | 0.7 | 0.5 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | NA | -10.2% | ||||
| Adj EPS ⓘ | NA | NA | NA | NA | ||||
| BVPSⓘ | NA | NA | NA | NA | ||||
| Share Price | - | - | - | - | ||||
Key Financial Parameters ⓘ
| Mar'25 | Mar'26 | TTM | |
|---|---|---|---|
| Return on Equity % ⓘ | 8.6 | -1 | -2.1 |
| Op. Profit Mgn % ⓘ | 7.7 | 1.8 | 2.7 |
| Net Profit Mgn % ⓘ | 4.1 | -0.5 | -1.1 |
| Debt to Equity ⓘ | 0.1 | 0 | - |
| Working Cap Days ⓘ | 0 | 123 | 41 |
| Cash Conv. Cycle ⓘ | 0 | 63 | 25 |
Valuation of DCM Shriram FineChem - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|
| Sales | 413 | 429 | 386 |
| Operating Expenses ⓘ + | 372 | 396 | 382 |
| Operating Profit ⓘ | 41 | 33 | 4 |
| Operating Profit Margin (%) | 9.8% | 7.7% | 0.9% |
| Other Income ⓘ + | 4 | 4 | 3 |
| Interest ⓘ | 2 | 2 | 1 |
| Depreciation ⓘ | 9 | 9 | 9 |
| Profit Before Tax ⓘ | 33 | 26 | -3 |
| Tax ⓘ | 9 | 7 | 0 |
| Profit After Tax | 24 | 19 | -4 |
| PAT Margin (%) | 5.9% | 4.5% | -0.9% |
| Adjusted EPS (₹) | 2.8 | 0.0 | -0.4 |
| Dividend Payout Ratio (%) | 26.90% | 0% | -98.40% |
| PARTICULARS | Mar'24 | Mar'25 | Mar'26 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 202 | 198 | 211 | ||||||||
| Debt + | 11 | 5 | 8 | ||||||||
| Minority Interest | 0 | 0 | 0 | ||||||||
| Trade Payables | 44 | 54 | 49 | ||||||||
| Others Liabilities ⓘ | 39 | 51 | 27 | ||||||||
| Total Liabilities ⓘ | 296 | 308 | 295 | ||||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 136 | 130 | 103 | ||||||||
| CWIP ⓘ | 1 | 0 | 0 | ||||||||
| Investments ⓘ | 23 | 23 | 33 | ||||||||
| Inventories | 44 | 50 | 41 | ||||||||
| Trade Receivables | 72 | 83 | 70 | ||||||||
| Cash Equivalents | 0 | 15 | 37 | ||||||||
| Others Assets ⓘ | 18 | 7 | 11 | ||||||||
| Total Assets ⓘ | 296 | 308 | 295 | ||||||||
| PARTICULARS | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 28 | 15 | 16 |
| Cash Flow From Investing Activity ⓘ + | -18 | 0 | 11 |
| Cash Flow From Financing Activity ⓘ + | -15 | -15 | -6 |
| Net Cash Flow ⓘ | -4 | 0 | 21 |
| PARTICULARS | Mar'24 | Mar'25 | Mar'26 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 11.96 | 9.61 | -1.73 | |||||||
| ROCE (%) | 16.28 | 12.61 | -0.76 | |||||||
| Asset Turnover Ratio | 1.41 | 1.43 | 1.29 | |||||||
| PAT to CFO Conversion(x) | 1.17 | 0.79 | N/A | |||||||
| Working Capital Days | ||||||||||
| Receivable Days | 63.50 | 65.30 | 71.80 | |||||||
| Inventory Days | 38.60 | 39.80 | 42.70 | |||||||
| Payable Days | 70.20 | 72.60 | 81.90 | |||||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
DCM Shriram Fine Chemicals Ltd FAQs
The current trading price of DCM Shriram FineChem on 11-Sep-2026 16:59 is ₹25.10.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 10-Sep-2026 the market cap of DCM Shriram FineChem stood at ₹218.3 Cr
The latest P/E ratio of DCM Shriram FineChem as of 10-Sep-2026 is 0.00.
The latest P/B ratio of DCM Shriram FineChem as of 10-Sep-2026 is 1.08.
The 52-week high of DCM Shriram FineChem is ₹52.49 and the 52-week low is ₹17.30.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of DCM Shriram FineChem is ₹386 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that DCM Shriram Fine Chemicals Ltd is a below average quality company.
The key valuation ratios of DCM Shriram Fine Chemicals Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of DCM Shriram Fine Chemicals Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.
About DCM Shriram Fine Chemicals Ltd
DCM Shriram Fine Chemicals (DSFCL) was incorporated as a public limited company on September 29, 2021 under the Companies Act, 2013 and a certificate of incorporation dated September 30, 2021 was issued by Central Registration Centre. DSFCL is one of the leading producers in the World for Pharmaceutical Intermediates, particularly in the Anti-Infective segment using Optical Isomer separation as its core competence. The company is also engaged in contract manufacturing and research for global pharmaceutical companies, leveraging these technologies to produce intermediates for various drug segments. Its chemical business has successfully absorbed 'state-of-the-art' technologies through affiliations with European companies, which have been crucial for upgrading its manufacturing processes and product portfolio.
Earlier, the company was a wholly owned subsidiary of DCM Shriram Industries limited. Pursuant to the scheme of arrangement becoming effective on December 17, 2025, the chemical business of DCM Shriram Industries Limited got demerged and vested in new entity with effect from April 1, 2023.
Fine Chemical business started in early 1970s with a manufacturing facility in Daurala (near Meerut), Uttar Pradesh using chemical processes with Photochlorination of Toluene, Cyanation etc. Over time, DCM Shriram Industries leveraged its process expertise to develop and manufacture value-added products and derivatives, with Photochlorination and Cyanation forming its core technological strengths. In 1994, a new unit was set up as a separate company namely Daurala Organics Limited, to produce high value/ high technology drug intermediates. Affiliations with three European companies were established to obtain state-of-the-art technology. This company was later merged into DCM Shriram Industries Limited.
Business area of the company
The company is engaged in the business of production and sale of chemicals and their by-products and also contract manufacturing of chemical products.
Products
- Pharmaceutical Intermediates
- Agrochemicals
- Dyes, Paints & Coatings:
- Perfumery & Fragrance
Milestones/ Major events
- 2021: Incorporation of the company as a wholly owned subsidiary of DCM Shriram Industries limited.
- 2025: The new structure, which officially took effect on December 17, 2025, separated the chemical and drug intermediates assets into its own standalone company with name DCM Shriram Fine Chemicals Limited.
- 2026: The newly formed entity was listed and began trading independently on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) on February 17, 2026.
You have 43 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
